A novel peptide blocking CD93/IGFBP7 interaction normalizes tumor vessels and synergizes with radiotherapy for cancer immunotherapy.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- A novel peptide blocking CD93/IGFBP7 interaction normalizes tumor vessels and synergizes with radiotherapy for cancer immunotherapy.
- Published In:
- Pharmacological research, 225, 108118 (2026)
- Authors:
- Qian, Yuzhen, Zhang, Qiongqiong, Wu, Yahong, Sun, Yixuan, Cheng, Ying, Shi, Peishang, Wang, Qingchao, Qiu, Lu, Wang, Mingshuang, Zhao, Wenshan, Zhai, Wenjie, Li, Lingling
- Database ID:
- RPEP-15942
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-15942APA
Qian, Yuzhen; Zhang, Qiongqiong; Wu, Yahong; Sun, Yixuan; Cheng, Ying; Shi, Peishang; Wang, Qingchao; Qiu, Lu; Wang, Mingshuang; Zhao, Wenshan; Zhai, Wenjie; Li, Lingling. (2026). A novel peptide blocking CD93/IGFBP7 interaction normalizes tumor vessels and synergizes with radiotherapy for cancer immunotherapy.. Pharmacological research, 225, 108118. https://doi.org/10.1016/j.phrs.2026.108118
MLA
Qian, Yuzhen, et al. "A novel peptide blocking CD93/IGFBP7 interaction normalizes tumor vessels and synergizes with radiotherapy for cancer immunotherapy.." Pharmacological research, 2026. https://doi.org/10.1016/j.phrs.2026.108118
RethinkPeptides
RethinkPeptides Research Database. "A novel peptide blocking CD93/IGFBP7 interaction normalizes ..." RPEP-15942. Retrieved from https://rethinkpeptides.com/research/qian-2026-a-novel-peptide-blocking
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.